Cutaneous Microthrombosis in a Patient With Factor V Leiden Heterozygosity and Antibodies to Phosphatidylserine/Prothrombin Complex
Francis A Nardella · 2024
Read Cutaneous Microthrombosis in a Patient With Factor V Leiden Heterozygosity and Antibodies to Phosphatidylserine/Prothrombin Complex by Francis A Nardella (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11661896.txt.
Description
Francis Nardella reports in 2024 a patient whose skin kept forming tiny clots from two stacked clotting risks: a Factor V Leiden gene variant and an unusual antibody against a phosphatidylserine-prothrombin complex. The antibody falls outside the standard criteria set, which is why such cases get missed. Standard clotting tests came back negative while the clinical picture shouted antiphospholipid trouble.
Treatment combined prednisone, the blood thinner apixaban, and rituximab, an antibody therapy. The harmful antibody level normalized, the skin events stopped, inflammation markers settled, and steroids could be withdrawn over 22 months. The report urges testing for nonstandard antibodies when suspicion is high, since the pairing of two mild risks may be more common than doctors realize.
Catalog record
| CREATOR | Francis A Nardella |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 15 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |